Combined RNAscope and immunofluorescence for CDH2, AXL, FAK, PD-L1, and miR-210, integrated with spatial transcriptomics, could map hybrid E/M niches and EV-linked immune states across tumor stages. The gene discussed is CDH2; the disease is neoplasm.